Tag Archives: FDA

‘Nonsensical’ Limits on Supportive Drugs Complicate Cancer Care

November 13, 2024 A young woman with breast cancer was experiencing such intense hot flashes from her triplet chemotherapy regimen, AC-T, that she begged to stop treatment. Her oncologist, Ramy Sedhom, MD, suggested she take oxybutynin, an inexpensive drug for overactive … Continue reading

Posted in FDA, Medicine, Medscape | Tagged , , , , , , , , , , | Leave a comment

Psychologists and Psychotropic Prescribing: An Old Debate Heats Up

December 13, 2024 Earlier this year, Utah became the seventh state to allow psychologists with the proper training to prescribe psychotropic medications, giving supporters reason to hope that more states might support expanding this scope of practice. However, the American … Continue reading

Posted in Health policy, Medicine, Medscape | Tagged , , , , , , , , | Leave a comment

Should the FDA Reconsider Antidepressant Boxed Warnings?

December 23, 2024 For almost two decades, antidepressants have carried boxed warnings linking the medications to an increased risk for suicidal thoughts and behaviors in young people. Paradoxically, and for almost as long, evidence suggests these warnings may have led … Continue reading

Posted in FDA, Health policy, Medicine, Medscape | Tagged , , , , , , , | Leave a comment

Califf Breezes Through Nomination Hearing for FDA Chief

WASHINGTON — Most members of a Senate committee had few reservations yesterday about Robert Califf’s qualifications to be the next commissioner of the US Food and Drug Administration (FDA). “You come here today with impressive qualifications,” said Senate Health, Education, … Continue reading

Posted in Health policy, Medscape | Tagged , , , , , | Leave a comment

Shifting Tactics in the Battle Against Influenza

When U.S. Food and Drug Administration experts met to pick viral targets for the next flu season, they also discussed a promising new way to create vaccines. Read more…

Posted in Medicine, Science, Science magazine | Tagged , , | Leave a comment